Search results for "tumor"

AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements

The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they have selected the "2026 Health...
Pregnancy Triggers Breast Immune Cells That May Help Suppress Cancer, Study Finds

Pregnancy Triggers Breast Immune Cells That May Help Suppress Cancer, Study Finds

While women who have gone through pregnancy and childbirth are known to carry a lower long-term risk of developing breast cancer, scientists have...
Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio

Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio

Novartis is significantly expanding its oncology portfolio after securing an antibody-drug conjugate technology...
Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer

Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer

Qurient announced on June 29 that it presented key clinical data highlighting the mechanistic advantages of its...
Born to Age Faster? How Accelerated Biological Aging Drives Rising Cancer Risk in Younger Generations

Born to Age Faster? How Accelerated Biological Aging Drives Rising Cancer Risk in Younger Generations

As cancer incidence inexplicably rises among younger adults worldwide, a pivotal new study suggests an unsettling...
Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy

Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy

Muscle mass in lung cancer patients may play a decisive role in determining the success of immunotherapy.
When High Blood Sugar Won’t Go Away: The Overlooked Warning Sign of Pancreatic Cancer

When High Blood Sugar Won’t Go Away: The Overlooked Warning Sign of Pancreatic Cancer

Pancreatic cancer is notoriously difficult to detect in its early stages because symptoms typically manifest late in...
When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

Crohn’s disease remains one of the most challenging inflammatory bowel diseases to manage.
Mapping Cancer’s Footprint: Specialized PET/CT Scans Pinpoint Metastasis and Recurrence

Mapping Cancer’s Footprint: Specialized PET/CT Scans Pinpoint Metastasis and Recurrence

Following a cancer diagnosis, patients and their families almost invariably ask the same urgent question: “How far has...
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological...